Your browser doesn't support javascript.
loading
Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial.
Busard, C I; Menting, S P; van Bezooijen, J S; van den Reek, J M; Hutten, B A; Prens, E P; de Jong, E M; van Doorn, M B; Spuls, P I.
Afiliação
  • Busard CI; Department of Dermatology, Academic Medical Center, Amsterdam, The Netherlands. c.i.busard@amc.uva.nl.
  • Menting SP; Department of Dermatology, Academic Medical Center, Amsterdam, The Netherlands.
  • van Bezooijen JS; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van den Reek JM; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Hutten BA; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, Amsterdam, The Netherlands.
  • Prens EP; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • de Jong EM; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Doorn MB; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Spuls PI; Department of Dermatology, Academic Medical Center, Amsterdam, The Netherlands.
Trials ; 18(1): 52, 2017 02 02.
Article em En | MEDLINE | ID: mdl-28148280
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Pele / Produtos Biológicos / Metotrexato / Fator de Necrose Tumoral alfa / Adalimumab / Imunossupressores Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Trials Assunto da revista: MEDICINA / TERAPEUTICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Pele / Produtos Biológicos / Metotrexato / Fator de Necrose Tumoral alfa / Adalimumab / Imunossupressores Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Trials Assunto da revista: MEDICINA / TERAPEUTICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Holanda